-+ 0.00%
-+ 0.00%
-+ 0.00%

ARVINAS : PHASE 1 ARV-102 SHOWED DOSE-DEPENDENT IMPROVEMENTS IN EYE MOVEMENT IN PARKINSON'S PATIENTS

路透·10/07/2026 11:03:07

請登錄查看新聞詳情